semaglutide stall Why You're Hitting a Weight-Loss Plateau on (and What to Do About It) Semaglutide Plateau: Why Weight Loss

The FDA will take action against those continuing to compound these medications after the enforcement deadlines

Clinical monitoring recommendations include: Baseline blood pressure measurement before initiating Zepbound Regular blood pressure and heart rate monitoring during dose titration (every 4-8 weeks) Assessment for orthostatic hypotension, particularly in patients taking antihypertensive medications Consideration of antihypertensive dose adjustments as weight loss progresses Monitoring of renal function and electrolytes in patients on diuretics or with significant gastrointestinal side effects Evaluation for medication-related adverse effects that might influence blood pressure (dehydration) Patients taking antihypertensive medications should be counseled about potential hypotension risk and instructed to report symptoms such as dizziness, lightheadedness, or syncope

10 Glycine

Oduwole, O